Alexis Tatter Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2407 Kentucky St, Louisiana, MO 63353 Phone: 573-754-5456 |
Miss Sarah Cathleen Geno, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2407 Kentucky St, Louisiana, MO 63353 Phone: 314-882-5747 |
Heather Spiker, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2407 Kentucky St, Louisiana, MO 63353 Phone: 573-754-5456 |
News Archive
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the close of its $16 million Series D round of financing. Current investors Caxton Advantage Life Sciences Fund LP and Sanderling Venture Partners co-led the round. In addition, the Series D structure grants certain current investors the option to invest an additional $4 million in this financing round in the future.
Therapies that soothe inflammation could be an effective way to prevent heart disease in people with a common age-related blood condition, according to a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons.
People with autism suffer from a pervasive developmental disorder of the brain that becomes evident in early childhood. Peter Scheiffele and Kaspar Vogt, Professors at the Biozentrum of the University of Basel, have identified a specific dysfunction in neuronal circuits that is caused by autism.
› Verified 2 days ago